Reduced Numbers and Impaired Function of Regulatory T Cells in Peripheral Blood of Ischemic Stroke Patients

Mediators of Inflammation

Volumn 2016, Issue , 2016, Pages

  Ruhnau, Johanna ^a   Schulze, Juliane ^a   Von Sarnowski, Bettina ^a   Heinrich, Marie ^a   Langner, Sönke ^a   Pötschke, Christian ^a   Wilden, Anika ^a   Kessler, Christof ^a   Bröker, Barbara M ^a   Vogelgesang, Antje ^a   Dressel, Alexander ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD39 ANTIGEN; CD40 LIGAND; TRANSCRIPTION FACTOR FOXP3; APYRASE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BLOOD; BRAIN ISCHEMIA; CD4+ T LYMPHOCYTE; CEREBRAL ARTERY DISEASE; CONTROLLED STUDY; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STROKE PATIENT; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; AGED; ANIMAL; CEREBROVASCULAR ACCIDENT; FEMALE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD; APYRASE; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; MICE; MIDDLE AGED; STROKE; T-LYMPHOCYTES, REGULATORY;

EID: 84962711835     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2016/2974605     Document Type: Article

References (31)

1. K. Prass, C. Meisel, C. Höflich et al., "Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation, " The Journal of Experimental Medicine, vol. 198, no. 5, pp. 725-736, 2003.
2. A. Vogelgesang and A. Dressel, "Immunological consequences of ischemic stroke: immunosuppression and autoimmunity, " Journal of Neuroimmunology, vol. 231, no. 1-2, pp. 105-110, 2011.
3. A. Vogelgesang, U. Grunwald, S. Langner et al., "Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke, " Stroke, vol. 39, no. 1, pp. 237-241, 2007.
4. A. Chamorro, S. Amaro, M. Vargas et al., "Catecholamines, infection, and death in acute ischemic stroke, " Journal of the Neurological Sciences, vol. 252, no. 1, pp. 29-35, 2007.
5. A. Hug, A. Liesz, B. Muerle et al., "Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia, " Stroke, vol. 42, no. 12, pp. 3580-3586, 2011.
6. T. Stubbe, F. Ebner, D. Richter et al., "Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO, " Journal of Cerebral Blood Flow and Metabolism, vol. 33, no. 1, pp. 37-47, 2013.
7. G. Yilmaz and D. N. Granger, "Leukocyte Recruitment and Ischemic Brain Injury, " NeuroMolecular Medicine, vol. 12, no. 2, pp. 193-204, 2010.
8. G. Enzmann, C. Mysiorek, R. Gorina et al., "The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury, " Acta Neuropathologica, vol. 125, no. 3, pp. 395-412, 2013.
9. S. Fumagalli, J. A. Coles, P. Ejlerskov et al., "In vivo real-time multiphoton imaging of T lymphocytes in themouse brain after experimental stroke, " Stroke, vol. 42, no. 5, pp. 1429-1436, 2011.
10. F. Ortolano, P. Maffia, G. Dever et al., "Advances in imaging of new targets for pharmacological intervention in stroke: realtime tracking of T-cells in the ischaemic brain, " British Journal of Pharmacology, vol. 159, no. 4, pp. 808-811, 2010.
11. K. J. Becker, D. L. Kindrick, M. P. Lester, C. Shea, and Z. C. Ye, "Sensitization to brain antigens after stroke is augmented by lipopolysaccharide, " Journal of Cerebral Blood Flow and Metabolism, vol. 25, no. 12, pp. 1634-1644, 2005.
12. J. M. Gee, A. Kalil, M. Thullbery, and K. J. Becker, "Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke, " Stroke, vol. 39, no. 5, pp. 1575-1582, 2008.
13. S. Sakaguchi, M. Miyara, C. M. Costantino, and D. A. Hafler, "FOXP3+ regulatory T cells in the human immune system, " Nature Reviews Immunology, vol. 10, no. 7, pp. 490-500, 2010.
14. A. Liesz, E. Suri-Payer, C. Veltkamp et al., "Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke, " Nature Medicine, vol. 15, no. 2, pp. 192-199, 2009.
15. C. Kleinschnitz, P. Kraft, A. Dreykluft et al., "Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature, " Blood, vol. 121, no. 4, pp. 679-691, 2013.
16. X. Ren, K. Akiyoshi, A. A. Vandenbark, P. D. Hurn, and H. Offner, "CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke, " Metabolic Brain Disease, vol. 26, no. 1, pp. 87-90, 2011.
17. A. Liesz, W. Zhou, S.-Y. Na et al., "Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke, " The Journal of Neuroscience, vol. 33, no. 44, pp. 17350-17362, 2013.
18. M. K. Schuhmann, P. Kraft, G. Stoll et al., "CD28 superagonistmediated boost of regulatory T cells increases thromboinflammation and ischemic neurodegeneration during the acute phase of experimental stroke, " Journal of Cerebral Blood Flow and Metabolism, vol. 35, no. 1, pp. 6-10, 2015.
19. J. Yan, S. J. Read, R. D. Henderson et al., "Frequency and function of regulatory T cells after ischaemic stroke in humans, " Journal of Neuroimmunology, vol. 243, no. 1-2, pp. 89-94, 2012.
20. M. Miyara and S. Sakaguchi, "Human FoxP3+ CD4+ regulatory T cells: Their knowns and unknowns, " Immunology and Cell Biology, vol. 89, no. 3, pp. 346-351, 2011.
21. S. Gallucci, M. Lolkema, and P. Matzinger, "Natural adjuvants: endogenous activators of dendritic cells, " Nature Medicine, vol. 5, no. 11, pp. 1249-1255, 1999.
22. P. Matzinger, "The danger model: A renewed sense of self, " Science, vol. 296, no. 5566, pp. 301-305, 2002.
23. G. Borsellino, M. Kleinewietfeld, D. DiMitri et al., "Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression, " Blood, vol. 110, no. 4, pp. 1225-1232, 2007.
24. M. Mandapathil, S. Lang, E. Gorelik, and T. L. Whiteside, "Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression, " Journal of Immunological Methods, vol. 346, no. 1-2, pp. 55-63, 2009.
25. K. Lahl, C. Loddenkemper, C. Drouin et al., "Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease, " Journal of ExperimentalMedicine, vol. 204, no. 1, pp. 57-63, 2007.
26. J. Yan, J. M. Greer, K. Etherington et al., "Immune activation in the peripheral blood of patients with acute ischemic stroke, " Journal of Neuroimmunology, vol. 206, no. 1-2, pp. 112-117, 2009.
27. D. Hill, N. Eastaff-Leung, S. Bresatz-Atkins et al., "Inhibition of activation induced CD154 on CD4+ CD25? cells: A valid surrogate for human Treg suppressor function, " Immunology and Cell Biology, vol. 90, no. 8, pp. 812-821, 2012.
28. Q. Li, Y. Wang, F. Yu et al., "PeripheralTh17/Treg imbalance in patients with atherosclerotic cerebral infarction, " International Journal of Clinical and Experimental Pathology, vol. 6, no. 6, pp. 1015-1027, 2013.
29. A. Jagger, Y. Shimojima, J. J. Goronzy, and C. M. Weyand, "Regulatory T cells and the immune aging process: A minireview, " Gerontology, vol. 60, no. 2, pp. 130-137, 2014.
30. M. A. Murray and S. H. Chotirmall, "The impact of immunosenescence on pulmonary disease, " Mediators of Inflammation, vol. 2015, Article ID692546, 10 pages, 2015.
31. A. Pera, C. Campos, N. López et al., "Immunosenescence: implications for response to infection and vaccination in older people, " Maturitas, vol. 82, no. 1, pp. 50-55, 2015.